BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9926631)

  • 1. Complications of sickle cell anemia in adults: guidelines for effective management.
    Ballas SK
    Cleve Clin J Med; 1999 Jan; 66(1):48-58. PubMed ID: 9926631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
    Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
    JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Digestives diseases associated to sickle cell anemia in Lubumbashi: epidemiological and clinical aspects].
    Banza MI; Mulefu JP; Lire LI; N'dwala YTB; Tshiamala IB; Cabala VPK
    Pan Afr Med J; 2019; 33():253. PubMed ID: 31692839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of CT and MR in imaging the complications of sickle cell disease.
    Howlett DC; Hatrick AG; Jarosz JM; Bingham JB; Cox TC; Irvine AT
    Clin Radiol; 1997 Nov; 52(11):821-9. PubMed ID: 9392459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phase 3 Trial of l-Glutamine in Sickle Cell Disease.
    Niihara Y; Miller ST; Kanter J; Lanzkron S; Smith WR; Hsu LL; Gordeuk VR; Viswanathan K; Sarnaik S; Osunkwo I; Guillaume E; Sadanandan S; Sieger L; Lasky JL; Panosyan EH; Blake OA; New TN; Bellevue R; Tran LT; Razon RL; Stark CW; Neumayr LD; Vichinsky EP;
    N Engl J Med; 2018 Jul; 379(3):226-235. PubMed ID: 30021096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approach to the vaso-occlusive crisis in adults with sickle cell disease.
    Yale SH; Nagib N; Guthrie T
    Am Fam Physician; 2000 Mar; 61(5):1349-56, 1363-4. PubMed ID: 10735342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical care of adult patients with sickle cell disease.
    Olujohungbe A; Howard J
    Br J Hosp Med (Lond); 2008 Nov; 69(11):616-9. PubMed ID: 19069260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic opioid use in patients with sickle cell disease.
    Mo G; Jang T; Stewart C; Khoury L; Ferguson N; Egini O; Muthu J; Dutta D; Salifu M; Lim SH
    Hematology; 2021 Dec; 26(1):415-416. PubMed ID: 34102090
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pain crises in patients with sickle cell diseases. Pathogenesis, clinical aspects, therapy].
    Dickerhoff R; von Ruecker A
    Klin Padiatr; 1995; 207(6):321-5. PubMed ID: 8569133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematologic emergencies. Management of transfusion reactions and crises in sickle cell disease.
    Dabrow MB; Wilkins JC
    Postgrad Med; 1993 Apr; 93(5):183-90. PubMed ID: 8460076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New issues in adult sickle sell disease].
    Girot R; Stankovic K; Lionnet F
    Bull Acad Natl Med; 2008 Oct; 192(7):1395-409; discussion 1409-11. PubMed ID: 19445365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.
    Ballas SK; Kesen MR; Goldberg MF; Lutty GA; Dampier C; Osunkwo I; Wang WC; Hoppe C; Hagar W; Darbari DS; Malik P
    ScientificWorldJournal; 2012; 2012():949535. PubMed ID: 22924029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactate Dehydrogenase: A Marker of the Severity of Vaso-Occlusive Crisis in Children with Sickle Cell Disease Presenting at the Emergency Department.
    García-Morin M; López-Sangüos C; Vázquez P; Alvárez T; Marañón R; Huerta J; Cela E
    Hemoglobin; 2016 Nov; 40(6):388-391. PubMed ID: 28361592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing sickle cell disease.
    Claster S; Vichinsky EP
    BMJ; 2003 Nov; 327(7424):1151-5. PubMed ID: 14615343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual causes of abdominal pain: sickle cell anemia.
    Ahmed S; Shahid RK; Russo LA
    Best Pract Res Clin Gastroenterol; 2005 Apr; 19(2):297-310. PubMed ID: 15833695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does hydroxyurea prevent pulmonary complications of sickle cell disease?
    Buckner TW; Ataga KI
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):432-7. PubMed ID: 25696890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Acute Sickle Cell Disease Pain.
    Payne JN; Gee BE
    Pediatr Rev; 2024 Jan; 45(1):26-38. PubMed ID: 38161155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
    Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
    Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strides made in red blood cell disorders, but substantial barriers to care remain.
    Hampton T
    JAMA; 2008 Jan; 299(4):395-6. PubMed ID: 18230771
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia.
    Miller ST; Wright E; Abboud M; Berman B; Files B; Scher CD; Styles L; Adams RJ;
    J Pediatr; 2001 Dec; 139(6):785-9. PubMed ID: 11743502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.